Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Connect Biopharma Holdings Limited CNTB

Set alert

Price alert · CNTB

All alert types
0.78 USD -0.03 -3.13%

At close · Nov 2

0.78 0.00 +0.37%

After hours · Nov 2, 4:00 PM ET

Bid
0.77 × 2
Ask
0.78 × 2
0.75 Day range 0.8099
0.732 52-week range 3.82
YTD
-72.44%
1 year
-54.56%
Open
0.8072
Prev close
0.8022
Mkt cap
48.94M
Vol
523.34K
Avg vol
3.99M
EPS
-1.19
P/E
0.00
Div yield
0.00%
More statistics
Low
0.75
High
0.8099
Forward P/E
-5.04
Beta
-0.31
Short ratio
1.93
Inst. own
44.43%
Dividend
0.00
Ex-div date
Earnings
Mar 30, 2023
50-d avg
1.12
200-d avg
1.34
1y target
7.00

MAX chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Feb 8, 2023Rating: SVB Leerink · — → Outperform
  • Mar 30, 2023Earnings: —; estimate -0.48; surprise —%
  • Sep 13, 2023Rating: Cantor Fitzgerald · Overweight → Overweight
  • Mar 4, 2024Rating: HC Wainwright & Co. · — → Buy
  • Apr 17, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Jun 13, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Sep 6, 2024Rating: HC Wainwright & Co. · Buy → Buy
Signals (101)
NameDateAgo
RSI: OversoldOct 19, 20262 weeks ago
SMA: BearishAug 24, 20262 months ago
SMA: BearishAug 17, 20262 months ago
SMA: BullishAug 10, 20262 months ago
SMA: BullishAug 10, 20262 months ago
SMA: BearishJul 20, 20263 months ago
SMA: BearishJul 13, 20263 months ago
SMA: BullishJul 6, 20264 months ago
SMA: BullishJun 29, 20264 months ago
SMA: BearishMay 4, 20266 months ago
SMA: BearishApr 20, 20266 months ago
MACD: Sell SignalApr 20, 20266 months ago
MACD: Buy SignalMar 23, 20267 months ago
SMA: BullishFeb 2, 20269 months ago
SMA: BearishJan 26, 20269 months ago
SMA: BullishJan 19, 20269 months ago
MACD: Sell SignalJan 12, 20269 months ago
SMA: BearishJan 5, 202610 months ago
MACD: Buy SignalNov 17, 202511 months ago
RSI: OverboughtNov 17, 202511 months ago

Newest 20 of 101.

Analyst view

Consensus: none

Price target (mean) 7.00 +800.8% upside
Target (low)
6.00
Target (mean)
7.00
Target (high)
8.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy1
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 2
  • 1 month ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

CNTB analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.000.000.0%00.0%0
Next quarter0.000.00 – 0.000.000.0%00.0%0
Current year-0.20-0.20 – -0.20-1.08+81.5%170.93M0.0%1
Next year0.000.00 – 0.00-0.20+100.0%280.15M+63.9%1

Upgrades and downgrades

The latest rating changes

CNTB analyst upgrades and downgrades
DateFirmActionFromTo
Sep 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jun 13, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 17, 2024HC Wainwright & Co.MaintainedBuyBuy
Mar 4, 2024HC Wainwright & Co.Initiated—Buy
Sep 13, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Feb 8, 2023SVB LeerinkMaintained—Outperform
Jun 2, 2022Cantor FitzgeraldInitiated—Overweight
May 5, 2022Piper SandlerDowngradeOverweightNeutral
May 4, 2022SVB LeerinkMaintained—Outperform
Jan 6, 2022SVB LeerinkMaintained—Outperform
Apr 13, 2021JefferiesInitiated—Buy
Apr 13, 2021SVB LeerinkInitiated—Outperform